Canada - English - Health Canada

nt pharma canada ltd - risedronate sodium (risedronate sodium monohydrate) - tablet - 35mg - risedronate sodium (risedronate sodium monohydrate) 35mg - bone resorption inhibitors

Canada - English - Health Canada

sanis health inc - risedronate sodium (risedronate sodium monohydrate) - tablet - 5mg - risedronate sodium (risedronate sodium monohydrate) 5mg - bone resorption inhibitors

Canada - English - Health Canada

sanis health inc - risedronate sodium (risedronate sodium monohydrate) - tablet - 30mg - risedronate sodium (risedronate sodium monohydrate) 30mg - bone resorption inhibitors

Canada - English - Health Canada

sanis health inc - risedronate sodium (risedronate sodium monohydrate) - tablet - 35mg - risedronate sodium (risedronate sodium monohydrate) 35mg - bone resorption inhibitors

Canada - English - Health Canada

abbvie corporation - risedronate sodium (risedronate sodium hemipentahydrate) - tablet (delayed-release) - 35mg - risedronate sodium (risedronate sodium hemipentahydrate) 35mg - bone resorption inhibitors

Canada - English - Health Canada

teva canada limited - risedronate sodium (risedronate sodium monohydrate) - tablet - 150mg - risedronate sodium (risedronate sodium monohydrate) 150mg - bone resorption inhibitors

United States - English - NLM (National Library of Medicine)

warner chilcott pharmaceuticals inc. - risedronate sodium (unii: ofg5exg60l) (risedronic acid - unii:km2z91756z) - risedronate sodium 150 mg - actonel is indicated for the treatment and prevention of osteoporosis in postmenopausal women. in postmenopausal women with osteoporosis, actonel reduces the incidence of vertebral fractures and a composite endpoint of nonvertebral osteoporosis-related fractures [see clinical studies (14.1, 14.2) ]. actonel is indicated for treatment to increase bone mass in men with osteoporosis. actonel is indicated for the treatment and prevention of glucocorticoid-induced osteoporosis in men and women who are either initiating or continuing systemic glucocorticoid treatment (daily dosage of ≥ 7.5 mg prednisone or equivalent) for chronic diseases. patients treated with glucocorticoids should receive adequate amounts of calcium and vitamin d. actonel is indicated for treatment of paget’s disease of bone in men and women. - abnormalities of the esophagus which delay esophageal emptying such as stricture or achalasia [see warnings and precautions (5.1) ] - inability to stand or sit upright for at least 30 minutes [see dosage

Canada - English - Health Canada

pharmascience inc - risedronate sodium (risedronate sodium hemipentahydrate) - tablet - 35mg - risedronate sodium (risedronate sodium hemipentahydrate) 35mg - bone resorption inhibitors

Canada - English - Health Canada

dominion pharmacal - risedronate sodium (risedronate sodium hemipentahydrate) - tablet - 35mg - risedronate sodium (risedronate sodium hemipentahydrate) 35mg - bone resorption inhibitors

Canada - English - Health Canada

pharmel inc - risedronate sodium (risedronate sodium hemipentahydrate) - tablet - 35mg - risedronate sodium (risedronate sodium hemipentahydrate) 35mg - bone resorption inhibitors